News TxCell

Equities

TXCL

FR0010127662

Real-time Euronext Paris Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	+67.53%

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TxCell : Sangamo and TxCell announce the completion of the acquisition by Sangamo of majority of TxCell ordinary shares	18-10-01	PR
TxCell : Sangamo Therapeutics to Acquire TxCell	18-07-23	PR
TxCell : exercises in-license option to the University of British Columbia’s intellectual property rights of the HLA-A2 CAR-Treg program	18-07-09	PU
TxCell : First in vivo proof-of-concept data with CD8+ CAR-Treg presented at FOCIS 2018	18-06-21	PU
TxCell : to present its latest manufacturing process achievements at the 3rd Annual Bioprocessing of Advanced Cellular Therapies Congress	18-05-28	PU
TxCell : 2016 financial results	17-04-06	PU
TxCell : to hold conference call on Friday, March 10, 2017 following the publication of its 2016 financial results	17-04-06	PU
TXCELL : September 2016 - TxCell to publish results for the first half of 2016 and to provide strategy update on Tuesday, September 27, 2016	16-09-25	PU
TxCell : appoints Biogen’s Dr. Olivier Danos, pioneer in gene therapy for neurological disorders, to its Scientific Advisory Board	16-09-05	PU
TxCell: financial information for the 2nd quarter of 2016	16-08-24	PU
TxCell : to participate in leading scientific conferences in Q3 2016	16-07-27	PU
TxCell : exercises option from Weizmann Institute of Science following effective grant of broad CAR-Treg patent in Europe	16-07-11	PU
TxCell : implements a new financing contract of up to €20 million in nominal value through convertible notes with warrants (OCABSA)	16-06-21	PU
TxCell : and the Lübeck Institute of Experimental Dermatology launch collaboration to develop CAR-Tregs in bullous pemphigoid	16-06-14	PU
TxCell : presents a series of new scientific data at the ISCT 2016 Annual Meeting	16-06-01	PU
TxCell: financial information for the 1st quarter of 2016	16-04-25	PU
TxCell : to participate in leading scientific conferences in Q2 2016	16-04-20	PU
TxCell : appoints PCT as its US manufacturing partner	16-03-31	PU
TxCell : 2015 results and update on strategy and outlook	16-03-15	PU
TXCELL : Key TxCell patent to be granted in Japan for its lead product Ovasave®	16-03-10	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer